Sarepta Therapeutics Community Letter: EMBARK Part 1 Topline Results

October 31, 2023

On October 30, 2023, Sarepta Therapeutics shared a Community Letter regarding topline results from the EMBARK study and more.

Please click here to view their Community Letter.

Accessible Vehicle Fund Applications Open